ROSE SOTO: Open Payments
NPI 1376591099 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,430 in 147 payments from 34 companies in 2025. Trend: 2023 $2,243 · 2024 $3,951 · 2025 $3,430
Food & beverage: $3,377Travel & lodging: $53
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $551 |
| UCB, Inc. | 10 | $457 |
| Abbott Laboratories | 6 | $256 |
| PFIZER INC. | 18 | $242 |
| Averitas Pharma Inc. | 3 | $169 |
| EMD Serono, Inc. | 4 | $154 |
| Lundbeck LLC | 6 | $131 |
| TG Therapeutics, Inc. | 4 | $105 |
| GENZYME CORPORATION | 4 | $104 |
| Alexion Pharmaceuticals, Inc. | 3 | $102 |
Products named: QULIPTA, Rystiggo, INFINITY, QUTENZA, NURTEC ODT, VYALEV, BRIUMVI, ULTOMIRIS.
Industry payments across NY — which companies pay providers there.
